NCT05493748

Brief Summary

According to International Urogynecological Association and International Continence Society joint report on the terminology for female pelvic floor dysfunction, overactive bladder syndrome (OAB) is defined as urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection or other obvious pathology. Bladder training lasting for a minimum of 4 to 6 weeks is indicated as a first-line treatment. The investigators' goal is to compare changes in satisfaction, measured in terms of quality of life, in 2 groups of women with different main accompanying symptoms in OAB (frequency vs. nocturia), before and after bladder training utilizing telemedicine (virtual bladder training), for 4 to 6 weeks.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 5, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 9, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

August 9, 2022

Status Verified

August 1, 2022

Enrollment Period

1.5 years

First QC Date

August 5, 2022

Last Update Submit

August 5, 2022

Conditions

Keywords

Overactive Bladder SyndromeBladder Training

Outcome Measures

Primary Outcomes (2)

  • Change in King's Health Questionnaire (KHQ) score

    KHQ score: 0-100 points per domain. Higher scores mean a worse outcome.Ten points change in KHQ score, before and after bladder training.

    Change from Baseline King's Health Questionnaire at 6 weeks

  • Change in International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF) score

    ICIQ SF score: 0-21 points. Higher scores mean a worse outcome. Three points change in ICIQ-SF score, before and after bladder training.

    Change from Baseline International Consultation on Incontinence Questionnaire Short Form at 6 weeks

Study Arms (2)

Frequency

OTHER

Main symptom: Increased daytime urinary frequency: complaint that micturition occurs more frequently during waking hours than previously deemed normal by the woman.

Other: Bladder training

Nocturia

OTHER

Main symptom: Complaint of interruption of sleep one or more times because of the need to micturate.

Other: Bladder training

Interventions

Bladder training for overactive bladder syndrome.

FrequencyNocturia

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women over 18 years of age
  • Live in Buenos Aires City
  • Overactive Bladder Syndrome
  • Access to virtual appointment

You may not qualify if:

  • Previous overactive bladder syndrome treatment.
  • Prior stress urinary incontinence or pelvic organ prolapse surgery.
  • History of Neurogenic Bladder, pelvic organs prolapse or pelvic radiation.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Italiano de Buenos Aires

Buenos Aires, Argentina

RECRUITING

Central Study Contacts

Agustina Vendramini, Dra.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Quasi-experimental, before-after trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 5, 2022

First Posted

August 9, 2022

Study Start

May 1, 2022

Primary Completion

October 31, 2023

Study Completion

December 31, 2023

Last Updated

August 9, 2022

Record last verified: 2022-08

Locations